Insiders · Profile

Lappe Mark

Chief Executive Officer at Inhibrx Biosciences. Filing since 20 Aug 2024. CIK 0001366074

Company

Date

Role

Action

Shares

Amount

Of holding

INBX Inhibrx Biosciences, Inc.

28 Sep 2026

Chief Executive Officer

Bought

4,500

$453.43K

0.6%

INBX Inhibrx Biosciences, Inc.

25 Sep 2026

Chief Executive Officer

Bought

5,500

$545.36K

0.8%

INBX Inhibrx Biosciences, Inc.

8 Sep 2026

Chief Executive Officer

Bought

25,000

$2.65M

3.5%

INBX Inhibrx Biosciences, Inc.

16 Sep 2024

Chief Executive Officer

Bought

13,037

$223.32K

1.9%

INBX Inhibrx Biosciences, Inc.

12 Sep 2024

Chief Executive Officer

Bought

26,963

$405.79K

4.1%

INBX Inhibrx Biosciences, Inc.

10 Sep 2024

Chief Executive Officer

Bought

8,500

$129.12K

1.3%

INBX Inhibrx Biosciences, Inc.

9 Sep 2024

Chief Executive Officer

Bought

9,500

$144.50K

1.5%

INBX Inhibrx Biosciences, Inc.

6 Sep 2024

Chief Executive Officer

Bought

26,000

$397.54K

4.2%

INBX Inhibrx Biosciences, Inc.

3 Sep 2024

Chief Executive Officer

Bought

20,000

$316.26K

13.8%

INBX Inhibrx Biosciences, Inc.

30 Aug 2024

Chief Executive Officer

Bought

10,000

$140.20K

7.4%

INBX Inhibrx Biosciences, Inc.

29 Aug 2024

Chief Executive Officer

Bought

10,000

$140.30K

8.0%

INBX Inhibrx Biosciences, Inc.

21 Aug 2024

Chief Executive Officer

Bought

12,945

$167.38K

30.9%

INBX Inhibrx Biosciences, Inc.

20 Aug 2024

Chief Executive Officer

Bought

27,055

$350.90K

182%

13 decisions on file.